Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol and Myo-inositol in PCOS
NCT04867252Phase 2Completed
- Sponsor
- Khyber Medical University
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of resveratrol and myo-inositol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Khyber Medical University. Primary endpoints: Insulin Resistance at 3 months, Hypoadiponectinemia at 3 months and 2 more. Started May 2021; status: completed.
02
Drugs
resveratrolmyo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04867252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867252.